Cancer immunotherapy has transformed oncology, yet many patients fail to respond or eventually develop resistance.

A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...

More than 400 cartons of Nilotinib capsules were voluntarily recalled by Cipla USA after failing manufacturing specifications ...

Great Novel Therapeutics Biotech & Medicals Corporation (GNTbm) (stock code: 7427) announced that its independently developed novel epigenetic immunoactivator GNTbm-38, with global rights for cancer ...

LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...

Doctors debunk viral myths about cancer diets, clarifying that sugar does not directly cause cancer and fasting cannot prevent it. Experts stress balanced nutrition and evidence-based treatment for ...

Scientists have experimented with bacteria as potential cancer therapy for a while now — some introduced to trigger an immune ...

A new purpose-built SACT centre in Tunbridge Wells will bring advanced cancer therapies and localised patient support to West Kent ...

A “significant number of patients” could see a cure for multiple myeloma within the next two decades, one expert told ...

Pazopanib produced responses and acceptable safety in paclitaxel-pretreated angiosarcoma; read more about outcomes and ...

Researchers have found hundreds of metabolic enzymes attached to human DNA inside the cell nucleus. Different tissues and cancers show unique patterns of these enzymes, forming a “nuclear metabolic ...

WACO, Texas - Baylor University researchers have published a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells.